Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -4641.39x is 76% below its 4-year average of -2637.86x, near the low end of its 4-year range (-4641.39x–-634.33x).
As of the fiscal period ended Tuesday, March 31, 2026.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-4641.39x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-2.21x
median of 261 covered companies
CURRENT VS SECTOR MEDIAN
-209917.78%
vs the sector median at left
Advanced Biomed Inc. Common Stock
Market Cap
$8.76M
Interest Coverage Ratio
-4641.39x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.37M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.75M
Interest Coverage Ratio
-1049.68x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.27M
Interest Coverage Ratio
-309.66x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.03M
Interest Coverage Ratio
-496.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.88M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.76M
Interest Coverage Ratio
-82777.81x
TTM Avg
11.97x
3Y Avg
11.97x
5Y Avg
11.97x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Advanced Biomed Inc. Common Stock (ADVB) | $8.76M | -4641.39x | N/A | N/A | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.37M | N/A | N/A | N/A | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | -1049.68x | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.79M | -19.65x | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.27M | -309.66x | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.03M | -496.55x | N/A | N/A | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | N/A | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.74M | -4.24x | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | -82777.81x | 11.97x | 11.97x | 11.97x |
| Aclarion, Inc. (ACON)vs › | $6.74M | N/A | N/A | N/A | N/A |
Interest Coverage
-4641.4x
Debt/Equity
0.08
Current Ratio
7.38
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -4641.39x |
| 2022-06-30 | -634.33x |
